For many years, the impact of hyper-and hypo-thermia on mammalian cells has been examined.
For many years, the impact of hyper-and hypo-thermia on mammalian cells has been examined. With the exception of short, low temperature storage, which has uses in areas such as preservation for transplantation or regenerative medicine, advantages for the use of low temperature treatment in hepatocytes have not been previously reported.
We have observed that alginate encapsulated HepG2 liver spheroids which are cryopreserved or experience a cold reduction in temperature (≤10°C) for periods between 1 and 90 minutes display an enhanced cell proliferation during culture 7-16 days post-treatment compared with untreated samples. Following 8-12 days post-treatment, alginate encapsulated liver spheroids experienced a cell density of 1.71±0.35 times that of control samples (p<0.001). This effect occurred in samples with a variety of cold treatments. 
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Introduction
Alginate encapsulation of cells is exploited for several purposes across a range of cell types (1) (2) (3) (4) (5) . The encapsulation of the HepG2 cell line to form alginate encapsulated liver spheroids (ELS) allows the HepG2 cells to proliferate using the alginate cross-linked with calcium (3, 6) as a 3-dimensional scaffold, increasing per-cell function compared to a cell monolayer (2, 7) . These ELS can be cultured in a fluidised bed bioreactor for potential use in an extracorporeal bioartificial liver (6) . Culture in a fluidised bed bioreactor is time, cost, and labour intensive, adding significantly to the overall cost of the device. Methods that reduce the culture time necessary for biomass production are highly desirable.
The cryopreservation of these ELS has been studied previously (8, 9) , and groups have examined the cryopreservation of other alginate encapsulated cell lines (7, 10, 11) . This has been done either to preserve ELS once a sufficient cell density has been achieved, or to explore the possibility that alginate encapsulation may offer some cryoprotection. It was in the course of our work that we observed a stimulatory effect on cell proliferation within ELS following freezing and thawing (9, (12) (13) (14) . In this study, the potential for low temperatures to induce proliferation of alginate encapsulated cells upon return to culture conditions has been examined in detail. We studied both the impact of chilling (low temperature exposure without freezing) and freezing (ultralow temperature in the presence of ice) in the presence of protective agents such as dimethyl sulfoxide (Me 2 SO) or those found in Viaspan (16, 21, (23) (24) (25) (26) .
Materials and Methods
Cell Culture and Encapsulation
Cell Culture -Static ELS Culture ELS were added to T175 flasks filled with warmed culture medium of modified alpha-MEM, supplemented with 50 U/ml penicillin, 50μg/ml streptomycin (all Invitrogen, Paisley, UK) 0.5% 1M 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The encapsulation method has been described previously (6) . The entire process is carried out at room temperature.
Cooling/Warming Methods
Chilling
Unless otherwise stated, cryoanaptiksi low temperatures wasere induced by plunging the samples (1mL solutions of ELS with 1mL excess medium in 2mL cryovials) into the centre of an ice bucket.
Care was taken to ensure the whole sample was covered in ice and samples were not agitated during the chilling test. Upon completion of the test time (1 -90 minutes), samples were removed from the ice bucket and transferred into 37°C culture medium prior to re-culture.
For cooling rate studies, samples were cooled as above, or in an EF600 freezer (Asymptote, Cambridge, UK) at 0.3°C min -1 from 20°C to 0°C. Rapid cooling was achieved by pipetting 1mL samples of ELS directly into 9mL culture medium precooled at 0°C, to induce classical cold-shock (15) (16) (17) . To test a 10°C chilling condition, samples were placed into an EF600 sample holder which had been pre-cooled and maintained at 10°C.
To determine temperatures in cryovials, a dummy solution containing 10% glycerol (G5516, Sigma) in 0.15M NaCl was prepared and added to cryovials with an inserted thermocouple (Picotechnology, St Neots, UK). This was attached to a Picologger (Picotechnology) and recorded using a computer.
This solution has previously been determined to have the same thermal properties as ELS in culture medium (9) . This solution was allowed to equilibrate for 5 minutes, before being filled into 5 separate cryovials, to a 2mL final volume. The cryovials were then cooled from 4°C to -100°C at 0.3°C min -1 in an EF600
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controlled rate freezer.
Upon completion of the cooling run, cryovials were transferred to liquid nitrogen storage.
Cryopreservation Thawing Protocol
Samples were removed from liquid nitrogen storage and thawed in a 37°C water bath until the last ice crystal had melted. This process took 330 seconds. The freezing mix was washed out in a stepwise manner using culture medium chilled to 4°C (9) . Warm culture medium (37°C) was added, and the ELS placed in culture at 37°C, in a 5% CO 2 humidified incubator.
Post-thaw Functional Assessments Viability
At designated time points, ELS were removed from culture and stained with 20μl propidium iodine solution (PI, 1mg/mL, Sigma) and 10μl fluorescein diacetate solution (FDA 1mg/mL, Sigma) to view under a fluorescent microscope. quantified by a method that has previously been outlined (9, 12) .
Cell Counts
Total cell number was determined using an NC-200 automated counting system (Chemometric, Allerod, Denmark). The ELS were liberated from alginate using a 16mM EDTA solution (Applichem, Darmstadt, Germany) before being washed in phosphate buffered saline (PBS, Sigma) and disaggregated by vigorous syringing through a 21G needle.
All cells were lysed in solution and the nucleolus stained with PI. This solution was drawn into the automated counter and the stained nuclei counted. As HepG2 cells are mono-nuclear, this was converted to a cell density for the total ELS present.
Metabolic Activity Assay
A tetrazolium salt (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay known as MTT (Invitrogen) was used to determine cell viability. 0.5 mL of a 0.75% (w/v) MTT solution was added to a small volume of ELS in vials with lids porous to gas. The vials were transferred to a 37°C, 5% CO 2 humidified incubator for 3 h to allow crystal formation. After incubation, 0.5mL acidified (4 mM HCl) iso-propanol (W292907, Sigma) solution was added to stop the reaction and dissolve the crystals. This solution was added to a 96-well plate, 100μl per well, and the absorbance at 570nm of each well was determined with an ANTHOS III plate reader (Biochrom, Cambourn, UK). The absorbance values were normalised against a control sample.
Glucose Consumption
Healthy HepG2 cells consume glucose during normal cell function. Samples of the culture medium were taken throughout the culture process, and the remaining glucose concentration measured with 
Enzyme-linked Immunosorbent Assay
Enzyme-linked immunosorbent assays (ELISAs) to determine alpha-1-fetoprotein (AFP) production in ELS was carried out on culture medium samples removed during the culture process. A sandwich ELISA using mouse monoclonal antibodies ab10071 and ab10072 (Abcam, Cambridge, UK) as a capture, and as a horse radish peroxidase linked antibody respectively, with Applichem fetoprotein (A6935) used for a standard curve. The values were normalized either to cell density or ELS volume.
Imaging
A phase contrast microscope was used to visually inspect ELS, with images recorded using Nikon
Imaging Software.
Statistics
Unless otherwise stated, figures are presented as an average of 5 replicates, ± 1 standard deviation. p values were determined through an appropriate t-test, with significance determined at p<0.001 unless otherwise stated. p values for raw data are stated in figure legends. variation in cell density occurs due to natural variation in the system, explaining the variations seen in control values, which has also been noted previously (6) . An increase in cell number was apparent following both cryopreservation and chilling for 45 minutes. When placed into an ice bucket, the sample temperature fell below 10°C after approximately 80 seconds, and below 4°C after 3 minutes.
Results
Cold Treatment in Culture Medium
Impact of Duration and Temperature of Cold Exposure
Cell viability was recorded as 96.5 ± 0.7%, 96.1 ± 0.5%, 95.9 ± 1.1%, and 94.3 ± 1.4% for ELS samples experiencing no low temperatures, 30 minute hold at 0°C, 45 minutes at 0°C, and 90 minutes in an ice bucket, resulting in a viable cell density of 18.5 ± 1.6, 29.5 ± 3.8, 33.2 ± 3.2, and 36.1 ± 3.5 million cells/mL respectively.
While the encapsulation process takes place at room temperature, Figure 3 also demonstrates that cooling samples to only 10°C for 45 minutes is sufficient to induce rapid cell growth, with a day 8 cell density of 19.1 ± 1.6 and 41.6 ± 4.3 million cells/mL for the control and cooled sample. This translates to a viable cell number 2.13 ± 0.22 times that of the control (p<0.001).
Cooling Rate and Time Dependency of Low Temperature Treatment
To determine whether the rate of initial cooling was critical for the cryoanaptiksi increased proliferation to become apparenteffect, five conditions were tested: (ii) Plunging 2 mL samples within cryovials into an ice bucket, and holding for 60 minutes prior to re-warming.
(iii) Pipetting 1 mL ELS into 9ml pre-cooled culture medium (at 0°C) to induce immediate cooling, and re-warming after 1 minute.
(iv) Pipetting 1 mL ELS into pre-cooled culture medium (at 0°C) to induce immediate cooling, and re-warming after 30 minutes.
(v) Cooling samples linearly from 20°C to 0°C at 0.3°C min -1 in cryovials in an EF600
Cell viabilities for each of the experimental conditions tested were 98.5 ± 0.4%, 98.8 ± 0.2%, 98.0 ± 1.5%, 98.9 ± 0.2%, and 98.4 ± 1.0% for (i) through (v) respectively (figure 3). 12 days post thaw a viable cell number of 27.3 ± 1.8, 24.6 ± 1.8, 31.9 ± 2.4, 29.0 ± 0.9, and 30.9 ± 2.2 million cells/mL was recorded for (i) through (v) respectively, as is shown in Figure 4 . Untreated controls had 96.5 ± 0.7% viability and 15.6 ± 1.6 million cells/mL 12 days post-thaw.
Effect of Chilling Versus Cryopreservation
Experiments were carried out to determine if the different stresses, either chilling or cryopreservation followed by rapid thaw, have a different effect on the magnitude of cell proliferation. Figure 5 shows a representative effect from 12 days of re-culture, for two separate experiments (Sets A and B).
Set A showed chilled and cryopreserved samples with a viable cell number of 35.1 ± 1.3 (p<0.001 vs control) and 32.9 ± 1.6 million cells/mL (p<0.005 vs control) respectively compared with 25.6 ± 5.4 million cells/mL for the control cells. 
Effect of Cryopreservation Reagents
Cryopreservation, but not chilling, includes the additional experimental variable of exposure to cryoprotectants. Thus the effect of chilling with and without these reagents was investigated.
Furthermore, the addition of Viaspan with no chilling was studied using 45 minutes culture at 37°C.
At 12 days post-treatment, viable cell density was determined to be significantly improved (p<0.001) over the control set for samples ELS chilled in both 12% DMSO and 38% Viaspan, ELS chilled in only culture medium, and ELS incubated in 38% Viaspan at 37°C or chilled in Viaspan. Samples thawed after cryopreservation showed significant improvement over control (p<0.005) as seen in Figure 6 .
ELS incubated in Viaspan at 37°C showed no significant improvement in cell density over the control samples. All chilled and cryopreserved samples apart from when ELS was chilled with only DMSO were significantly better than the control (p<0.001). For the Viaspan sets, chilled samples showed significant improvement over control samples (p<0.001). Figure 7 shows the impact of cryopreservation on cell number over a period of 12 days post-thaw culture. Cells were initially encapsulated at a density of 1.92 ± 0.2 million cells mL -1 .
Time-course of Cell Proliferation
For the first 7 days of culture, the cryopreserved samples had a lower viable cell number compared to control samples. On day 8, the cryopreserved samples began to show signs of cryoanaptiksi increased proliferation and overtook the control samples in terms of viable cell numbers. Viable cell numbers were 9.0 ± 1.6 million cells mL -1 for the control versus 6.9 ± 1.0 million cells mL -1 for cryopreserved samples at day 5. Viable cell numbers were 11.5 ± 1.0 million cells mL -1 for the control versus 12.8 ± 1.0 million cells mL -1 for cryopreserved samples at day 8, and 17.9 ± 2.5 million cells Significant break-out of spheroids from the alginate was observed above around 50 million cells mL -1 , which likely affected growth above this cell density.
Unencapsulated Cells
A study was undertaken where a cell suspension in a cryovial was chilled and then returned to T175 flask culture. Confluence was measured for 7 days after which point the flasks became fully confluent. No significant difference was seen between a chilled samples and an unchilled control.
Cold Impact on Cell Function and Extended Culture
The metabolic changes of the ELS following chilling or cryopreservation, measured by MTT assay, was significantly improved over control samples at days 5, 7, and 11 post-treatment ( Figure 8A ).
Glucose consumption per mL biomass over 24 h is indicative of cell metabolism. There was no significant difference between the rate of glucose consumption in the ELS at any measured timepoint (days 7, 8, and 12) in line with their increase in cell numbers ( Figure 8B ). However, alphafetoprotein (AFP) production per mL biomass over 24 h was significantly higher in fresh samples over cryopreserved samples. 
Discussion
In this paper we have demonstrated that alginate encapsulated liver spheroids that are cryopreserved or experience a reduction in temperature (≤10°C) for periods between 1 and 90 minutes display a greatly enhanced cell proliferation during culture 7-16 days post-treatment compared with untreated samples.
There is an extensive literature of the effects of low temperatures on mammalian cells and tissues, but we are not aware of any instances where an increase in cell proliferation was reported. We have termed this new phenomenon cryoanaptiksi (cryo -cold; anaptiksi -growth).
The majority of studies examining low temperature exposure on cells report negative consequences of low temperatures. The extent of these reports range from slower cell proliferation through to apoptosis and necrosis (16, (18) (19) (20) (21) (22) (23) (24) (25) . Specific stages of the cell cycle can be disproportionately affected (26) , the G1 of the cell cycle seems particularly sensitive to the impact of low temperatures, with cells being observed to accumulate in this phase (16, 24, 27 ). The only field in which low temperatures are regularly used on mammalian tissues without freezing are in cell/tissue preservation and surgery (16, 22, 28, 29) .
To our knowledge, no studies have reported the effects of cold culture temperatures to induce rapid cell proliferation; indeed, the consensus is that low temperatures are to be strenuously avoided. 14 We have not investigated the underlying mechanisms of cryoanaptiksi this effect in this study. They may be related to cold-shock proteins, or recovery mechanisms remaining active when the initial insult of temperature reduction has passed. A previous study found no differences in alginate measured by FTIR between cryopreserved and non-cryopreserved (or chilled) control samples (30).
The effect was not seen in cell suspensions, however as rapid growth may have only been apparent around 7 days post-treatment, the effect may have been masked as culture beyond this point in T175 flasks results in cell detachment in the HepG2 system. Accelerated cell growth was seen at all initial cell densities tested, varying between 1.5 million cells/ml and 2.13 million cells/ml. A 45 minute chill test carried out at a higher cell density of 20 million cells/ml (12 days after encapsulation) did not result in increased proliferation, however this may have been a consequence of cell break-out from the cell beads, resulting in an upper cap on ELS cell density.
Cryoanaptiksi Low temperature treatment has little time dependence, with samples cooled and warmed over the space of a minute still displaying increased cell proliferation compared to the uncooled control, indicating that the mechanism for inducing increased growthcryoanaptiksi is triggered very rapidly. While many cell types cannot survive rapid temperature fluctuations (12, 19) , encapsulated HepG2 cells seem largely immune to above zero temperature fluctuations. This, combined with observed cryoanaptiksi for cold storage times between 1 and 90 minutes all inducing increased proliferation will allow this method to be used robustly in large volumes, where consistent cooling and warming times and rates are difficult to obtain across a sample. The biophysical mechanism response for this phenomenon is unclear but could be related to phase changes in membrane lipids, alteration in the cytoskeleton coupled with the unique physical environment that the cells encounter within the cross-linked alginate.
Inducing cryoanaptiksiCold treatment reduces cell number relative to the control for several days, consistent with previous literature (9, 31, 32) . It can take up to 7 days for the cell spheroids to Alpha-1-fetoprotein (AFP) production tends to be reduced during rapid proliferation. In these data, the overall performance was slightly reduced in the cryopreserved samples. As cell density was higher in the cryoanaptiksicold-experienced sample, this indicates a large reduction of around 50%
in per-cell performance during the 12-day growth period. In this system, protein production tends to be inversely proportional to cell proliferation, as during the growth cycle cellular resources are directed to proliferation and not protein production. Studies examining the effects of low temperatures on hepatocytes found that when holding the cells for 30 minutes at 4°C, albumin production was reduced up until around 7 days post-thaw, agreeing with observations in this study around the decreased AFP production. This decrease could be mitigated with addition of polyethylene glycol (34) . Albumin quantification was not undertaken in this study owing to the presence of human plasma in our culture medium, thus AFP was chosen as the indicative protein.
MTT and glucose consumption was maintained after cryoanaptiksi cold treatment indicating that the cell spheroids were healthy. Viability tends to be slightly lower after cold treatment, this is due to the higher cell density making nutrient transfer more difficult. In most cases the effect was <3%, and was taken into account in viable cell numbers. Viability remained suitably high throughout, above 90% in all test conditions.
The BAL is intended for use after a 12 day initial growth period, between approximately 12-15 days post-encapsulation (6) . Cell function in this study shows increased protein production as cell growth rate slows. For effective delivery of these treatments, it would be beneficial to develop a method to Methods such as adding a small extra layer to the outside of alginate beads have been shown to stop cell proliferation when the alginate bead is full and prevent cell break-out (3).
A major consideration when developing bioartificial organs is the prolonged time required for cell culture to achieve sufficient cell number for therapeutic use. By employing low temperature treatment to ELS, we have shown that cell proliferation can be greatly upregulated, allowing a more economical cell-growth regime, reducing biomass volume required for treatment, and so substantially reducing costs. In summary, making these devices cheaper to culture, quicker to prepare, and more practical.
Cold treatment could also allow for the possibility of very large volumes of ELS being prepared at the same encapsulation, with cryopreservation and thaw on demand and treatment commencing within 8-9 days as opposed to 26 days which is the current set-up (6, 8, 9, 30) . Exact volumes dependant on patient needs could also be determined prior to thaw, removing the one-size-fits-all of many BAL systems, and instead tailoring to specific patient needs without the requirement of an additional thaw.
Optimal growth has been observed in this system when the ELS have an initial cell density of 2 million cells/mL at the start of the culture period. For cell types that experience a reduced viable cell number post-thaw, it would be feasible to have a pre-freeze cell density proportionally above the optimal level, which reduces to the optimum on thaw, resulting in ideal cell growth conditions.
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